CN Patent

CN105833279B — 皮肤多种损伤创面治疗的外用药物组合物及其制备方法

Assigned to Individual · Expires 2021-06-22 · 5y expired

What this patent protects

本发明涉及一种治疗皮肤多种损伤创面的液态外用药物组合物。该组合物的特征在于具有很强的吸湿保湿性，能快速地封闭创面。该组合物可抗氧化、有效地抑菌灭菌、保护创面的生发细胞免受进一步损害，消除创面水肿，促进创面愈合。该药物组合物可广泛地用于治疗烧伤、皮肤擦挫伤、割裂伤、感染性皮肤疮疡创面的暴露治疗，节省敷料，使用方便、高效。

USPTO Abstract

本发明涉及一种治疗皮肤多种损伤创面的液态外用药物组合物。该组合物的特征在于具有很强的吸湿保湿性，能快速地封闭创面。该组合物可抗氧化、有效地抑菌灭菌、保护创面的生发细胞免受进一步损害，消除创面水肿，促进创面愈合。该药物组合物可广泛地用于治疗烧伤、皮肤擦挫伤、割裂伤、感染性皮肤疮疡创面的暴露治疗，节省敷料，使用方便、高效。

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN105833279B
Jurisdiction: CN
Classification: —
Expires: 2021-06-22
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.